Overview

Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients

Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the safety and the therapeutic effect of Decitabine in the treatment of elderly Acute Myeloid Leukemia (AML) patients.
Phase:
Phase 3
Details
Lead Sponsor:
Jianxiang Wang
Collaborator:
Xian-Janssen Pharmaceutical Ltd.
Treatments:
Azacitidine
Decitabine